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Abstract
Background: Progressive left ventricular dilatation (PLVD) occurs after myocardial infarc-
tion (MI), and this may take place in the area of primary percutaneous coronary intervention
(PCI). The factors predicting PLVD after primary PCI still need to be clarified. The aim of the
study was to assess the prevalence and to define the baseline clinical and echocardiographic
predictors of PLVD in patients with STEMI treated by primary PCI.
Methods: Of the 90 patients initially selected for the study 88 (29 women and 59 men, mean
age 67.1 – 5.6 years) with first ST-elevation myocardial infarction (STEMI) treated with
primary PCI were examined. Echocardiographic examination was performed in all patients at
discharge (M1) and after 6 months (M2). The following factors influencing PLVD were
evaluated: type of infarct-related artery (IRA), infarct size expressed as wall motion score index
(WMSI) ‡ 1.5, left ventricular end-diastolic volume index (LVEDVI) ‡ 80 ml/m2, ejection
fraction (EF) £ 45%, restrictive pattern of transmitral flow, time to reperfusion, left ventricular
mass index (LVMI) ‡ 125 g/m2 and coronary risk factors.
Results: The overall prevalence of PLVD (according to the criterion of 20% LVEDVI increase
from M1 to M2) was 24%. Univariate regression analysis revealed that the following were the
significant baseline M1 predictors of adverse PLVD: left anterior descending as IRA (relative risk:
rr = 2.3, p< 0.05), WMSI ‡ 1.5 (rr = 4.29, p< 0.005), EF £ 45% (rr = 2.89, p < 0.005) and
a restrictive pattern of transmitral flow (rr = 2.4, p< 0.01). Multivariate logistic analysis
showed that the only independent determinant of PLVD was WMSI ‡ 1.5.
Conclusions: Both regional and global left ventricular systolic dysfunction indices as well as
severe left ventricular diastolic abnormalities but not left ventricular dilatation at discharge
are significant predictors of adverse cardiac remodelling after STEMI in patients treated with
primary PCI. However the only independent determinant of PLVD was WMSI ‡ 1.5 express-
ing the infarct size. (Cardiol J 2007; 14: 238245)
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Introduction
Complex alterations in the architecture and
function of the left ventricle (LV) following myo-
cardial infarction (MI), referred to as LV remod-
elling, can affect the patients prognosis [13].
LV remodelling is a heterogeneous process, involv-
ing both infarcted and non-infarcted zones, which
effects wall thickness and chamber size, shape and
function. LV dilatation following MI precedes de-
terioration of exercise performance and plays a role
in the development of chronic heart failure [13].
From a clinical viewpoint LV remodelling is
a dynamic process starting in the acute phase with
an infarct expansion, leading to myocardial thinning
and lengthening and progressing to LV dilatation [1].
It is known that early reperfusion treatment
improves survival by limiting infarct size and con-
sequently preserving LV function. Early reper-
fusion therapy and patency of the infarct-related
artery (IRA) is crucial for reducing infarct expan-
sion and LV enlargement [24].
The favourable effects of early IRA patency on
LV remodelling are suggested by several studies
in the thrombolysis area [24]. Recently there has
been increased interest in the prevalence of remod-
elling in the area of the interventional cardiology.
Some investigators have tested the hypothesis that
LV remodelling occurs after percutaneous coronary
intervention (PCI), despite persistent patency of the
IRA, and may influence the prognosis [5, 6].
From a clinical viewpoint it is important to
identify those patients at high risk of LV remodel-
ling. The extent of the baseline myocardial damage
is linked to the magnitude and the timing of LV dil-
atation [7]. The development of LV remodelling
expressed by progressive left ventricular dilatation
(PLVD) after MI is a complex process influenced
by many factors. Infarct size, anterior location, the
perfusion status of the IRA, a restricted pattern of
LV filling and heart failure on admission have been
identified as predictors of LV dilatation after MI in the
thrombolysis area [2]. The factors predicting PLVD
after MI treated by PCI remain to be clarified.
The purpose of the study was to assess the
prevalence of PLVD patterns during the first
6 months after MI treated with primary PCI and to
define at discharge the clinical, angiographic and
echocardiographic predictors of the PLVD pattern.
Methods
Of the 90 patients initially selected for the
study 2 were excluded owing to inadequate echocar-
diography image quality. The study group consist-
ed of 88 patients (29 women and 59 men, mean age
67.1 – 5.6 years) with first ST elevation myocar-
dial infarction (STEMI), who had been referred to
the catheterisation laboratory and were undergo-
ing primary PCI. Perfusion of the infarct region by
the IRA was assessed according to the criteria of
the Thrombolysis in Myocardial Infarction (TIMI)
Trial [8]. Primary PCI was performed < 12 h from
the onset of symptoms. The patients with clinical
signs of congestive acute heart failure or cardiogen-
ic shock in the first week after MI, post-infarction
angina, significant mitral regurgitation or valve dis-
ease were excluded, as well as subjects with atrial
fibrillation, atrioventricular conduction abnormali-
ties and pacemaker insertion.
Complete M-mode, two-dimensional echocar-
diography and Doppler ultrasound examination
were performed with SONOS Image-Point at the
time of discharge (M1) and 6 months after MI (M2).
LV volume and ejection fraction (EF) were meas-
ured using Simpsons formula (rule algorithm). The
LV volume indices were obtained by dividing the
volume of the body surface area [9]. The mean val-
ues of three measurements of the technically best
cardiac cycles were taken from each examination
performed by two independent inter-observers.
In each patient the wall motion score index
(WMSI) was derived. The LV was divided accord-
ing to a 16-segment model. For each segment wall
motion was scored from 1 (normal) to 4 (dyskinetic).
The ratio of the short axis cavity area to the apical
four-chamber cavity area (long axis) at end-diasto-
le was taken as a sphericity index.
LV mass was calculated by the formula intro-
duced by Devereux at al. [10] and normalised to the
body surface area to obtain the left ventricular mass
index (LVMI). Left ventricular hypertrophy (LVH)
was considered as LVMI > 125 g/m2.
From the echo Doppler LV diastolic filling pattern
the following variables were calculated at baseline: peak
velocity of early rapid filling wave E, peak velocity of
atrial wave A, peak E/A wave velocity ratio and DT.
A restrictive pattern was considered as DT < 140 ms.
An increase in left ventricular end-diastolic
volume index (LVEDVI) > 20% between M1 and
M2 was considered as a PLVD pattern. According
to the PLVD pattern, patients were divided into two
groups: group I (n = 25) with PLVD (D+) and group
II (n = 65) without PLVD (D).
The following factors baseline influencing
PLVD were evaluated:
 type of IRA: left anterior descending (LAD) vs.
non-LAD;
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 multivessel coronary artery disease;
 symptom to balloon time ‡ 4 h;
 percentage of stenting;
 2 or more risk factors (diabetes, hypertension,
smoking, dyslipidemia);
 infarct size expressed by WMSI ‡ 1.5;
 LVEDVI ‡ 80 ml/m2;
 left ventricular end-systolic volume index
(LVESVI) ‡ 40 ml/m2; cut-off values of LVEDVI
and LVESVI were established on the basis of
the mean values plus two standard deviations
in the control group;
 EF (by Simpsons method) £ 45%;
 LVH, defined as LVMI ‡ 125 g/m2;
 R-restrictive patterns of transmitral flow con-
sidered as DT < 140 ms).
Statistical analysis
For each parameter mean, median and stand-
ard deviation were calculated. Statistical signifi-
cance between means for different groups was cal-
culated by the non-parametrical Wilcoxon signed
rank test (the number of cases was too small to use
parametrical tests). Statistical significance between
frequencies was calculated by the c2 test with Yates
correction or, if the expected value was less than 5,
by Fishers exact test. Relative risk (rr) and confi-
dence interval were also calculated. A p value of less
than 0.05 was required to reject the null hypothesis.
Statistical analysis was performed using the EPIINFO
Ver. 3.3.2 (09022005) software package. The fol-
lowing clinical, angiographic and echocardiographic
variables were taken into account in univariate anal-
ysis: type of IRA (LAD vs. non-LAD), the presence of
multivessel coronary artery disease, symptom to bal-
loon time > 4 h, 2 or more risk factors (diabetes,
hypertension, smoking, dyslipidemia), WMSI ‡ 1.5,
LVEDVI ‡ 80 ml/m2, LVESVI ‡ 40 ml/m2, EF £ 45%,
LVMI ‡ 125 g/m2 and the presence of restrictive pat-
terns of transmitral flow. The variables that were
significant in univariate analysis were entered into
multivariate models.
Results
The clinical and angiocardiographic character-
istics of patients in group I, n = 25 (D+) and in
group II, n = 63 (D) are shown in Table 1. Neither
group showed any difference with regard to age,
sex, hyperlipidemia, diabetes or hypertension, nor
were there differences regarding the time of onset
of symptoms to reperfusion. There was no differ-
ence in the groups with respect to the extent of
coronary artery disease or TIMI flow grade. There
was no significant difference in the percentage of
stenting between the groups, 80% in group I (D+)
vs. 81% in group II (D) (Table 1).
LAD as the IRA was more common in patients
with PLVD in group I (D+) with an incidence of
48% compared to 20.6% in group II (D); p < 0.05.
The groups did not differ with respect to
therapy in secondary prevention: aspirin, statins
and beta-blockers, although ACE-inhibitor ther-
apy was recommended during 6-month follow-up
more often in group I (D+), 96% vs. 38% in group
II (D). We had no influence on therapy after dis-
charge. In group I (D+) 26% of patients had
revascularisation procedures during the 6-month
follow-up in comparison with 20% of patients in
group II (D); NS.
The overall prevalence of PLVD, according to
the criterion of a 20% LVEDVI increase from M1
to M2, was 24%. The echocardiographic baseline
characteristics of patients with and without PLVD
Table 1. Baseline (M1) clinical and angiographic characteristics of patients in group I (D+) and
group II (D).
Group I (D+), n = 25 Group II (D), n = 63 p
Age [years] 57.5 – 10.6 60.9 – 11.8 Ns
Sex (female/male) 5/20 24/39 Ns
Risk factors ‡ 2 3 (12%) 19 (30%) Ns
hyperlipidemia 8 (32%) 30 (47%) Ns
hypertension 11 (44%) 36 (57%) Ns
diabetes 4 (16%) 23 (36%) Ns
Infarct-related arteryleft anterior descending 12 (48%) 13 (20%) £ 0.05
Multivessel coronary artery disease 12 (48%) 19 (30%) Ns
TIMI flow grade > 2 20 (80%) 58 (92%) Ns
Percentage of stenting 20 (80%) 51 (81%) Ns
Symptoms to balloon time ‡ 4 h 17 (68%) 32 (50%) Ns
(D+)  patients with progressive left ventricular dilatation; (D)  patients without progressive left ventricular dilatation
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are shown in Table 2. The 6-month follow-up meas-
urements (M2) of the LV remodelling indices are
shown in Table 3.
The LVEDVI tended to be greater at base-
line in patients in group I (D+) than in group II
(D), but these differences were statistically in-
significant (Table 2). At baseline both global and
regional contractile functions were significantly
poorer in group I (D+) than in group II (D).
Changes in LV volume indices in both groups are
shown in Figures 1 and 2. A significant improve-
ment in EF was observed in group II (D), where-
as it remained unchanged throughout the study
period in group I (D +) (Fig. 3). WMSI remained
unchanged during the study period in both groups
(Fig. 4). In group I (D+) increasing LVEDVI and
LVESVI (Fig. 1, 2) were associated with increas-
ing distortion of the cavity shape towards the
spherical (Fig. 5).
At discharge and at 6-month follow-up the
sphericity index was significantly greater in group
I (D+), at 0.63 – – 0.07, than in group II (D), at
0.55 – 0.12 (Fig. 5).
Predictors of progressive
left ventricular dilatation
The univariate analysis took into account clin-
ical, angiographic and echocardiographic variables.
Table 2. Baseline (M1) echocardiographic characteristics of patients in group I (D+) and group II (D).
Group I (D+), n = 25 Group II (D), n = 63 p
LVEDVI [ml/m2] 74.2 – 16.4 69.6 – 13.1 NS
LVESVI [ml/m2] 36.9 – 12.1 29.1 – 11.1 £ 0.005
Ejection fraction [%] 46.7 – 8.3 55.3 – 7.0 £ 0.0001
Wall motion score index 1.87 – 0.51 1.47 – 0.34 £ 0.0001
Sphericity index 0.639 – 0.079 0.557 – 0.126 £ 0.05
Interventricular septum thickness [cm] 1.01 – 0.25 1.2 – 0.19 NS
Posterior wall thickness [cm] 0.90 – 0.15 1.11 – 0.2 NS
Left ventricular mass index [g/m2] 201.1 – 60.6 196.3 – 51.9 NS
E [cm/s] 0.61 – 0.20 0.56 – 0.20 NS
A [cm/s] 0.58 – 0.20 0.60 – 0.20 NS
Deceleration time [s] 0.150 – 0.035 0.162 – 0.020 NS
Isovolumetric relaxation time [s] 0.120 – 0.029 0.126 – 0.020 NS
(D+)  patients with progressive left ventricular dilatation; (D)  patients without progressive left ventricular dilatation; LVEDVI  left ventricular
end-diastolic volume index; LVESVI  left ventricular end-systolic volume index; E  peak of early filling wave; A  peak of atrial filling wave
Table 3. Six months follow-up (M2) echocardiographic indices of left ventricular remodelling pattern.
Group I (D+), n = 25 Group II (D), n = 63 p
LVEDVI  [ml/m2] 94.5 – 19.3 70.6 – 13.5 £ 0.0001
LVESVI  [ml/m2] 45.3 – 12.7 30.2 – 11.4 £ 0.0001
Ejection fraction [%] 46.4 – 11.4 57.1 – 7.8 £ 0.0001
Wall motion score index 1.87 – 0.61 1.45 – 0.36 £ 0.01
Sphericity index 0.646 – 0.105 0.558 – 0.208 NS
(D+)  patients with progressive left ventricular dilatation; (D)  patients without progressive left ventricular dilatation; LVEDVI  left ventricular
end-diastolic volume index; LVESVI  left ventricular end-systolic volume index
Figure 1. Changes in left ventricular end-diastolic volume
index (LVEDVI) in group I (D+) and group II (D); (D+) 
patients with progressive left ventricular dilatation; (D)
 patients without progressive left ventricular dilatation
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a restrictive pattern of transmitral flow were identi-
fied as at high risk of progressive dilatation. The sig-
nificant predictors of PLVD are listed in Table 4.
Figure 2. Changes in left ventricular end-systolic volu-
me index (LVESVI) in group I (D+) and group II (D);
(D+)  patients with progressive left ventricular dilata-
tion; (D)  patients without progressive left ventricu-
lar dilatation.
Figure 3. Changes in ejection fraction (EF) in group I
(D+) and group II (D); (D+)  patients with progressi-
ve left ventricular dilatation; (D)  patients without
progressive left ventricular dilatation.
The univariate regression analysis revealed that
patients with LAD as the IRA, a low EF £ 45%, with
a large infarct size expressed as WMSI ‡ 1.5 and
Figure 5. Changes in left ventricular sphericity index
(SI) in group I (D+) and group II (D); (D+)  patients
with progressive left ventricular dilatation; (D)  pa-
tients without progressive left ventricular dilatation.
Figure 4. Changes in wall motion score index (WMSI) in
group I (D+) and group II (D); (D+)  patients with
progressive left ventricular dilatation; (D)  patients
without progressive left ventricular dilatation.
Table 4. Baseline (M1) predictors of progressive left ventricular dilatation.
Univariate regression analysis p
Relative risk 95% confidence interval
Infarct related artery (LAD) 2.3 1.164.16 < 0.05
Wall motion score index ‡ 1.5 4.29 1.7710.4 < 0.005
Ejection fraction £ 45% 2.89 1.625.18 < 0.005
Restrictive pattern of mitral flow 2.4 1.204.83 < 0.001
LAD  left anterior descending
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In the present study neither end-diastolic volume
nor end-systolic volume was a significant predic-
tor of progressive dilatation. However, multivar-
iate logistic regression analysis after adjustment
for LAD as IRA, low EF £ 45%, WMSI ‡ 1.5 and
a restrictive pattern of transmitral flow showed
that the only independent determinant of PLVD
was WMSI ‡ 1.5 with rr = 4.20, p < 0.005.
Discussion
LV remodelling following MI is a complex proc-
ess involving changes in ventricular size, shape, and
mass. LV dilatation has routinely been used as
a surrogate for remodelling [2, 3]. Dilatation of the
LV may play an important role in the development
of chronic heart failure [1, 11].
LV remodelling after acute MI is stimulated by
the interaction of a number of factors, such as a loss
of contractile elements, activation of circulating
neurohormones and patency of the IRA, initial MI
size and LVH to normalise wall stress [13, 1114].
The benefits of primary PCI over thromboly-
sis in improving survival have been described [4].
One could expect a low prevalence of remodelling
processes following mechanical reperfusion. Our
data showed that, despite early mechanical reper-
fusion, PLVD occurred in 24% of patients success-
fully treated with primary PCI, which was very close
to the 34% observed in previous studies of throm-
bolysed patients [11].
Gaudron et al. [11] observed that 20% of pa-
tients develop progressive structural LV dilatation,
which is compensatory at first but is eventually
associated with progressive global cardiac dysfunc-
tion. The SAVE trial echocardiographic substudy,
consisting of 512 patients who survived an acute MI
with EF < 40%, showed that LV dilatation occurred
in more than one third within two years and was
associated with a deterioration in LV function [3].
The GISSI 3 echo substudy showed that late
remodelling is associated with progressive dete-
rioration of global ventricular functions and exten-
sive wall motion asynergy rather than significant
enlargement of ventricular volume before dis-
charge, constituting a high risk for progressive
dilatation [13].
In modern clinical practice the widespread use
of acute reperfusion strategies and anti-remodel-
ling medications was indicated in the REVE study
(Left Ventricular Remodelling After Anterior Wall
Acute Myocardial Infarction in modern Clinical
Practice) of 220 patients (29% treated with prima-
ry PCI, 54% thrombolysis), in which LV remodel-
ling (a 20% increase in LVEDVI) was shown in 31%
patients. Peak enzyme, WMSI and systolic blood
pressure have been independently associated with
LV remodelling [15].
Bolognese et al. [5] showed LV dilatation at
6 months with > 20% increase in LVEDVI in 30%
of a group of 284 patients undergoing primary PCI
for acute MI, despite an excellent IRA patency rate.
It was interesting that dilatation in general but not
a specific pattern of LV dilatation was associated
with a poor long term prognosis [5].
In contrast to other studies, we failed to ob-
serve the progressive deterioration of global LV
functions in patients with LV remodelling. In the
present study the EF in group I with (D+) remained
unchanged within the 6-month follow-up. The
mechanism of deteriorating LV function remains
unclear. It has been suggested that systolic and
diastolic dysfunctions of the non-infarcted myocar-
dium and regional hypertrophy play a role in the
deterioration of LV function [11].
The relative importance and predictive value
of identifying patients at high risk for progressive
dilatation and heart failure are not known. The ear-
ly identification of patients at a risk of LV dilatation
may have important therapeutic implications.
Our study supports the concept that LV remod-
elling following MI is a heterogeneous process. In
univariate analysis infarct size expressed by WMSI
‡ 1.5, type of IRA (LAD), EF £ 45% and a restrict-
ed pattern of LV filling at discharge have been iden-
tified as predictors of LV dilatation after MI. In the
present study neither LVEDVI nor LVESVI was
a significant predictor of progressive dilatation.
LVEDVI ‡ 80 ml/m2 at discharge did not differ be-
tween groups (D+) and (D), although multivariate
logistic stepwise analysis showed the only inde-
pendent determinant of PLVD to be WMSI ‡ 1.5.
These findings are consistent with those of the
GISSI 3 echo substudy in the thrombolytic area, which
showed extensive wall motion asynergy rather than
a significantly enlarged ventricular volume before dis-
charge to be a high risk for progressive dilatation [13].
Our data are also in accordance with the Bolog-
nese study, in which independent predictors of pro-
gressive dilatation were a relatively low LVEDVI and
a high WMSI. These authors revealed that primary
PCI progressive dilatation can be expected in patients
with a large functional infarct size expressed by a high-
er WMSI and confirmed the concept that the adap-
tive compensatory nature of early remodelling (early
dilatation) is not necessarily progressive [5].
The importance of LV diastolic dysfunction in
the development of LV dilatation and heart failure
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has been noted [6, 16]. There are few papers eval-
uating both systolic and diastolic functions which
indicate LV dilatation predictors after MI [6].
Our findings revealed that the restrictive fil-
ling pattern appeared to be a significant predictor
of LV remodelling in unifactorial analysis but was
not independent of other variables in multivariate
analysis. Cerisano at al. [6] showed that the restric-
tive pattern was an independent predictor of LV dil-
atation in patients treated with primary PCI and that
the extent of asynergy and peak creatine kinase (as
estimates of infarct size) were significantly higher
in patients with a short DT. Doppler indices of LV
filling are affected by a number of other physiolog-
ical factors including heart rate, LV systolic func-
tions and ventricular preload and afterload [17].
It is known that reperfusion therapy of MI causes
abnormal LV stiffness and relaxation. Some stud-
ies suggest that reperfusion in MI is associated with
diastolic stunning [18]. Obviously DT is inverse-
ly related to the LV filling pressure. LV filling pres-
sure can subsequently influence LV dilatation ow-
ing to changes in wall stress [6].
The occurrence of diabetes was similar in the
two groups. In the literature diabetes is not shown
as an independent predictor of subsequent LV re-
modelling. Carrabba et al. [19], at 6 months after
MI treatment by PCI, found a similar incidence of
LV remodelling in the group with diabetes as in that
without. In diabetic patients a greater LV chamber
stiffness was noted, indicating that LV diastolic
dysfunction may play a role in the development of
heart failure [19]. In a population of patients in the
SAVE study (Survival and Ventricular Enlarge-
ment) Solomon et al. [20] showed that in those with
diabetes heart failure cannot be explained by an in-
creased propensity for LV remodelling.
It has recently been noted that many factors,
such as the advancement of coronary artery disease,
recurrent ischemia, coronary microcirculation dys-
function and myocardial viability, can influence LV
remodelling in the angioplasty area [2123]. In con-
trast to our results, those of the Bolognese group [5]
showed that the presence of multivessel coronary
artery disease was an independent predictor of pro-
gressive dilatation, suggesting the role of progres-
sive ischemia in triggering adverse LV remodelling.
Recent studies have also confirmed that microvas-
cular dysfunction is important in subsequent chang-
es in LV geometry [21, 22]. Petronio et al. showed
that primary PCI associated with abciximab en-
hanced myocardial reperfusion and reduced
6-month LV remodelling [24].
Our study, as well as others in the area of me-
chanical reperfusion, highlights remodelling as
a heterogeneous process and suggest that factors
other than infarct size and IRA patency may play
a role in triggering LV remodelling after MI. This
problem requires further observation and studies
in order to answer the questions raised.
Patients following MI with early mechanical
reperfusion and patent IRA, non-significantly
dilated LV or a larger extent of wall motion abnor-
mality at discharge are at risk of developing late
adverse LV remodelling. These patients should be
monitored by serial echocardiographic examina-
tions so that therapy may be introduced to prevent
or reverse the remodelling.
Limitation of the study
The main limitation of our study was a lack of
knowledge of late IRA patency. We were unable to
perform the control coronarography at 6-month fol-
low-up and thus cannot exclude the possibility that
recurrent ischemia may have played a role in trig-
gering the remodelling process. The objective of
reperfusion therapies should be not only to achieve
rapid and sustained epicardial patency but also to
restore microvascular flow and myocardial tissue
perfusion. We did not evaluate the impact of micro-
vascular damage on LV remodelling.
A further limitation is the relatively short ob-
servation period, as the remodelling process may
take place over successive years.
Conclusions
Both regional and global left ventricular systo-
lic dysfunction indices and severe left ventricular
diastolic abnormalities rather than left ventricular
dilatation at discharge are significant predictors of
adverse cardiac remodelling in patients with ST
elevation myocardial infarction treated by primary
percutaneous coronary intervention. However the
only independent determinant of progressive left
ventricular dilatation is a wall motion score index
of ‡ 1.5 expressing the infarct size.
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